Literature DB >> 12644521

Topical treatments for onychomycosis: a historical perspective.

Myron A Bodman1, Lisa Feder, Angela M Nace.   

Abstract

Topical treatment of onychomycosis, in contrast to systemic oral therapy, allows the patient to apply medication directly to the affected area, thereby decreasing the potential for adverse events and drug interactions. Historically, several topical antifungal agents have been used in the treatment of onychomycosis; however, the evidence for their effectiveness is based on very limited data or anecdotal reports. Recently, the development of new, effective topical agents has renewed interest in this form of therapy. As clinical experience with newer topical agents expands, they may be found to be an effective option for the treatment of onychomycosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644521     DOI: 10.7547/87507315-93-2-136

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  3 in total

1.  An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine.

Authors:  Anroop B Nair; Hyun D Kim; Shawn P Davis; Robert Etheredge; Michael Barsness; Phillip M Friden; S Narasimha Murthy
Journal:  Pharm Res       Date:  2009-07-07       Impact factor: 4.200

2.  Evaluation of the Ability of a Novel Miconazole Formulation To Penetrate Nail by Using Three In Vitro Nail Models.

Authors:  Luisa Christensen; Rob Turner; Sean Weaver; Francesco Caserta; Lisa Long; Mahmoud Ghannoum; Marc Brown
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

3.  The use of urea for the treatment of onychomycosis: a systematic review.

Authors:  S Dars; H A Banwell; L Matricciani
Journal:  J Foot Ankle Res       Date:  2019-04-11       Impact factor: 2.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.